Fig. 2: UBP310 rescues the loss of SNc DA neurons in parkinQ311X mice.

Representative images showing TH immunoperoxidase labeling in the SNc of the WT and the parkinQ311X mice (6 months of age) treated with either vehicle or UBP310 (20 mg/kg i.p.) for 90 or 135 days. The graph below the picture shows DA neuron quantification performed by stereological count. Data are the means ± SEM of TH-positive neurons: WT treated with vehicle for 90 days 5578 ± 235 n = 8 mice, WT treated with UBP310 for 90 days 5351 ± 162 n = 7 mice, parkinQ311X treated with vehicle for 90 days 4701 ± 117 n = 11 mice, parkinQ311X treated with UBP310 for 90 days 5347 ± 107 n = 12 mice, parkinQ311X mice treated with UBP310 for 135 days 5514 ± 94 n = 9 mice, one-way ANOVA followed by Tukey’s test F = 6.681, WT vehicle 90 days vs. parkinQ311X vehicle 90 days ***p = 0.0007, WT UBP310 90 days vs. parkinQ311X vehicle 90 days *p = 0.0260, parkinQ311X vehicle 90 days vs. parkinQ311X UBP310 90 days **p = 0.0073, parkinQ311X vehicle 90 days vs. parkinQ311X UBP310 135 days **p = 0.0012.